Microchip Technology
+6%
est. 2Y upside i
Rank
#3464
Sector
Semiconductors
Est. Liquidity
~1Y
Data Quality
Data: HighMicrochip Technology is a publicly traded large-cap (NASDAQ: MCHP) where RSUs vest into immediately liquid shares — there is no startup-style liquidity-event risk.
Last updated: May 5, 2026
PCIe Gen 6 data-center design wins accelerate and the industrial/embedded inventory correction fully clears by mid-2026, lifting revenue toward ~$5.5B in FY2027 and restoring 25–30% net margins. The market cap re-rates to ~$75–80B on a recovered earnings multiple, delivering ~50% appreciation from the current $51.6B base.
Revenue stabilizes around $4.5–4.8B by FY2027 as channel inventory normalizes and automotive/industrial end markets gradually recover, but the already-elevated ~11.8x trailing P/S multiple limits further re-rating. RSUs vest into low-double-digit appreciation, with market cap drifting to ~$58–62B.
Prolonged industrial weakness and aggressive price competition from Texas Instruments and NXP push revenue down toward $3.8–4.0B, while negative net income and CEO insider selling catalyze multiple compression from ~11.8x to ~7–8x P/S. Market cap falls to ~$28–35B, erasing roughly a quarter of current value within two years.
Preference Stack Risk
lowFunding Intensity
0%Microchip Technology is publicly traded (NASDAQ: MCHP) with no venture preference stack; RSUs convert 1-for-1 into common shares with zero liquidation overhang.
Dilution Risk
lowAnnual employee RSU issuance at a $51.6B large-cap typically represents ~1–2% dilution per year, immaterial relative to stock price movements.
Secondary Liquidity
activeMCHP shares trade on NASDAQ with tens of millions of dollars in average daily volume; vested RSUs are fully liquid with no lock-up restrictions.
Questions to Ask at the Interview
Strategic questions based on Microchip Technology's data — designed to show you've done your homework.
- 1
“How is Microchip tracking its PCIe Gen 6 design-win pipeline relative to Broadcom and Marvell, and what is management's expected revenue contribution timeline and deal size per win?”
- 2
“With revenue down ~8% in FY2025 and net income negative, what specific end-market leading indicators — book-to-bill, distributor inventory days, automotive backlog — tell you the correction has bottomed and when do you expect a return to historical 30%+ net margins?”
- 3
“What is the RSU grant size, vesting schedule (cliff plus ramp), and does the company offer annual refreshes or performance-based equity that would make up for periods of stock underperformance?”
Community
Valuation Sentiment
Our model estimates +6% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.